Biology’s code. We write it.
Quantum Codon combines dark genome mining, quantum computing, and AI to unlock novel therapeutics across disease areas—faster and more precisely than ever.
90%
of genome code remains unused
$2.6B
per drug development cost
10yr
discovery timeline
Problem to solution
From pipeline fragility to new molecular territory
Quantum Codon frames the discovery problem in business terms: less dependence on saturated target spaces, stronger prioritization, and clearer paths to validated candidates.
The Drug Discovery Pipeline Is Broken
Traditional pipelines rely on a small fraction of the genome and are failing to deliver. High costs, low success rates, and long timelines leave patients waiting and innovation out of reach.
Unlocking Biology’s Dark Matter
We explore the uncharted 90% of the genome—dark matter of biology. By decoding its hidden potential with quantum power and AI precision, we discover entirely new medicines.
Convergent technology
Three revolutionary technologies converge
Each capability is valuable on its own. Together, they form a discovery engine built for unexplored biology and faster evidence generation.
Dark Genome Mining
- Systematically uncovers overlooked coding regions
- Proprietary annotation and ranking methods
- Turns hidden biology into candidate libraries
Quantum Computing
- Simulates complex biological interactions
- Ranks molecular optimization pathways
- Accelerates high-dimensional structure search
AI Integration
- Learns functional signals across datasets
- Optimizes for efficacy, safety, and delivery
- Closes the loop between compute and wet lab
Platform architecture
A readable path from dark genome discovery to lab validation
The platform is designed as a disciplined operating system: search broadly, simulate deeply, prioritize intelligently, and validate experimentally.
Dark Genome Scan
Identify novel coding sequences from unused genomic regions.
Quantum Simulation
Model interactions and rank therapeutic potential.
AI Optimization
Optimize for potency, safety, delivery, and manufacturability.
Wet Lab Validation
Synthesize and test top candidates experimentally.
Novel therapeutics
Therapeutic Pipeline
Quantum Codon’s discovery space supports a portfolio strategy across neglected infections, resistant pathogens, oncology targets, and neurodegenerative disease.
Antiparasitics
Novel peptides and small molecules targeting neglected parasitic infections.
Antimicrobials
Next-generation antibiotics designed for drug-resistant pathogens.
Oncology
Precision-targeted therapies for solid and blood cancers.
Alzheimer’s
Blood-brain barrier-aware therapies for neurodegeneration.
Beyond
Beyond Therapeutics
Industrial Enzymes
Novel biocatalysts for sustainable industry and environmental solutions.
Diagnostics
High-specificity signatures for earlier detection and monitoring.
Research Tools
Reagents, assays, and platforms for the life science community.
Market opportunity
Massive untapped market opportunity
A platform approach gives Quantum Codon multiple commercial paths while preserving the upside of first-mover position in an emerging molecular category.
Pharma Market
$1T+
Global opportunity across therapeutics and platform partnerships.
Diagnostics
$100B+
Precision signatures for early detection and longitudinal care.
Industrial Enzymes
$37B+
Sustainable industrial and environmental applications.
Featured insight
Our addressable market spans therapeutics, diagnostics, and industrial applications, with first-mover advantage in a new molecular space.
Competitive advantage
Compounding competitive advantage
The platform is designed to improve as data, validation, partnerships, and candidate feedback compound over time.
First Mover Position
Pioneering the field of dark genome and quantum-powered discovery.
Proof of Concept Achieved
Validated hits across multiple target classes and therapeutic areas.
High Barrier to Entry
Quantum infrastructure, datasets, and AI create meaningful moats.
Proprietary Datasets
Curated dark genome annotations and biological data assets.
Integrated Capabilities
End-to-end platform from computation to validation feedback.